Rolapitant treats lung cancer by targeting deubiquitinase OTUD3
Tongde Du(China Pharmaceutical University), Jifeng Feng(Nanjing Medical University)
Cited by 11
Related Papers
Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
|International Journal of Nanomedicine|2017|241
Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression
|PLoS ONE|2015|118
The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis
|Nature Communications|2019|117
Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3
|Cell Death and Disease|2020|65